XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 50.46%567.6M | 50.46%567.6M | 5.41%409.06M | -9.35%321.64M | 50.44%397.2M | 124.09%377.24M | 124.09%377.24M | 136.91%388.08M | 114.38%354.82M | -24.54%264.02M |
-Cash and cash equivalents | 41.13%319.1M | 41.13%319.1M | 11.35%213.2M | 14.96%208.05M | 16.36%185.91M | 48.04%226.11M | 48.04%226.11M | 25.41%191.46M | 16.99%180.97M | -43.36%159.77M |
-Money market investments | 64.43%248.5M | 64.43%248.5M | -0.39%195.86M | -34.66%113.59M | 102.68%211.29M | 868.44%151.13M | 868.44%151.13M | 1,665.43%196.62M | 1,507.19%173.85M | 53.71%104.25M |
Receivables | 19.91%35.87M | 19.91%35.87M | 15.99%32.55M | 13.98%30.62M | 15.25%29.33M | 16.56%29.92M | 16.56%29.92M | 24.97%28.06M | 21.31%26.86M | 26.31%25.45M |
-Accounts receivable | 19.91%35.87M | 19.91%35.87M | 15.99%32.55M | 13.98%30.62M | 15.25%29.33M | 16.56%29.92M | 16.56%29.92M | 24.97%28.06M | 21.31%26.86M | 26.31%25.45M |
Net loan | 19.67%5.93B | 19.67%5.93B | 6.11%5.18B | 5.46%5.12B | 6.01%5.05B | 8.43%4.95B | 8.43%4.95B | 11.02%4.88B | 19.00%4.86B | 27.52%4.76B |
-Gross loan | 19.80%5.98B | 19.80%5.98B | 6.08%5.22B | 5.40%5.16B | 5.94%5.09B | 8.40%4.99B | 8.40%4.99B | 11.07%4.92B | 19.09%4.9B | 27.64%4.8B |
-Allowance for loans and lease losses | 35.70%54.84M | 35.70%54.84M | 2.49%42.15M | -1.43%41.41M | -1.59%41.17M | 5.86%40.41M | 5.86%40.41M | 16.84%41.13M | 30.00%42.01M | 43.03%41.83M |
Securities and investments | 2.31%934.65M | 2.31%934.65M | 8.31%955.65M | 0.14%913.85M | -3.49%907.84M | -1.58%913.51M | -1.58%913.51M | -4.55%882.3M | -5.43%912.6M | -4.44%940.68M |
-Available for sale securities | 21.09%41.1M | 21.09%41.1M | 21.37%39.56M | 11.43%38.81M | -4.90%34.94M | -9.41%33.94M | -9.41%33.94M | -17.26%32.59M | 14.92%34.82M | 59.50%36.74M |
-Short term investments | 1.59%893.55M | 1.59%893.55M | 7.81%916.09M | -0.31%875.05M | -3.43%872.9M | -1.26%879.57M | -1.26%879.57M | -3.98%849.7M | -6.09%877.77M | -5.97%903.95M |
Bank owned life insurance | 21.94%117.65M | 21.94%117.65M | 5.69%101.36M | 5.65%100.68M | 5.59%100.06M | 4.92%96.48M | 4.92%96.48M | 8.07%95.91M | 7.84%95.3M | 29.99%94.76M |
Net PPE | 17.95%81.95M | 17.95%81.95M | 4.55%67.62M | 8.74%68.55M | 7.26%68.72M | 9.98%69.48M | 9.98%69.48M | 1.43%64.67M | -1.97%63.04M | 1.69%64.07M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 7.86%120.15M | 7.86%120.15M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -5.09%-50.67M | -5.09%-50.67M | ---- | ---- | ---- |
Foreclosed assets | 228.13%5.53M | 228.13%5.53M | 14.70%1.79M | 24.95%1.98M | -1.90%1.34M | 22.81%1.69M | 22.81%1.69M | 85.48%1.56M | 60.30%1.59M | -0.29%1.37M |
Goodwill and other intangible assets | 38.43%138.82M | 38.43%138.82M | 1.04%101.85M | 0.83%102.38M | 0.82%102.9M | -2.24%100.29M | -2.24%100.29M | -2.23%100.81M | -2.31%101.54M | -3.29%102.06M |
-Goodwill | 37.54%121.57M | 37.54%121.57M | 3.55%91.53M | 3.37%91.53M | 3.37%91.53M | -0.17%88.39M | -0.17%88.39M | -0.17%88.39M | -0.34%88.54M | -1.52%88.54M |
-Other intangible assets | 45.04%17.25M | 45.04%17.25M | -16.85%10.33M | -16.50%10.85M | -15.87%11.37M | -15.29%11.9M | -15.29%11.9M | -14.75%12.42M | -13.91%12.99M | -13.45%13.52M |
Other assets | 17.71%18.15M | 17.71%18.15M | 54.20%19.96M | 58.77%16.19M | 87.84%13.63M | 59.91%15.42M | 59.91%15.42M | 68.44%12.95M | 13.33%10.19M | -6.96%7.26M |
Total assets | 19.33%7.86B | 19.33%7.86B | 6.16%6.89B | 3.86%6.7B | 6.45%6.7B | 9.92%6.58B | 9.92%6.58B | 11.75%6.49B | 16.71%6.45B | 17.30%6.29B |
Liabilities | ||||||||||
Total deposits | 24.05%6.51B | 24.05%6.51B | 8.67%5.64B | 10.95%5.56B | 15.95%5.57B | 8.89%5.25B | 8.89%5.25B | 13.18%5.19B | 7.65%5.01B | 3.19%4.81B |
Federal funds purchased and securities sold under agreement to repurchase | 19.78%22.62M | 19.78%22.62M | -7.38%21.53M | -20.60%18.45M | -45.01%17.21M | -44.89%18.89M | -44.89%18.89M | 5.31%23.25M | 25.72%23.23M | 34.04%31.29M |
Payables | -59.78%5.97M | -59.78%5.97M | -66.46%3.75M | -41.08%4.52M | 11.87%3.93M | 609.42%14.84M | 609.42%14.84M | 993.65%11.19M | 982.77%7.67M | 292.51%3.51M |
-Accounts payable | -59.78%5.97M | -59.78%5.97M | -66.46%3.75M | -41.08%4.52M | 11.87%3.93M | 609.42%14.84M | 609.42%14.84M | 993.65%11.19M | 982.77%7.67M | 292.51%3.51M |
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.82%9K | -99.82%9K | -55.00%9K |
-Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.82%9K | -99.82%9K | -55.00%9K |
Long term debt and capital lease obligation | -25.24%460.64M | -25.24%460.64M | -23.77%472.02M | -46.81%410.08M | -49.66%413.14M | 17.18%616.19M | 17.18%616.19M | -4.73%619.23M | 108.34%770.98M | 318.39%820.73M |
-Long term debt | -25.24%460.64M | -25.24%460.64M | -23.77%472.02M | -46.81%410.08M | -49.66%413.14M | 17.18%616.19M | 17.18%616.19M | -4.73%619.23M | 108.34%770.98M | 318.39%820.73M |
Other liabilities | 37.23%57.07M | 37.23%57.07M | 27.14%50.88M | 14.18%42.64M | 29.21%39.5M | 51.62%41.59M | 51.62%41.59M | 15.93%40.02M | 14.96%37.35M | 12.25%30.57M |
Total liabilities | 18.81%7.06B | 18.81%7.06B | 5.18%6.19B | 3.17%6.04B | 6.22%6.05B | 9.80%5.94B | 9.80%5.94B | 11.05%5.88B | 15.12%5.85B | 16.04%5.69B |
Shareholders'equity | ||||||||||
Share capital | 4.32%101.48M | 4.32%101.48M | 0.18%97.45M | 0.16%97.43M | 0.17%97.42M | 0.25%97.28M | 0.25%97.28M | 2.81%97.27M | 330.82%97.27M | 330.98%97.25M |
-common stock | 16.57%29.55M | 16.57%29.55M | 0.69%25.52M | 0.62%25.5M | 0.65%25.49M | 0.96%25.35M | 0.96%25.35M | 12.12%25.34M | 12.25%25.34M | 12.21%25.32M |
-Preferred stock | 0.00%71.93M | 0.00%71.93M | 0.00%71.93M | 0.00%71.93M | 0.00%71.93M | 0.00%71.93M | 0.00%71.93M | -0.11%71.93M | --71.93M | --71.93M |
Paid-in capital | 25.81%500.02M | 25.81%500.02M | 0.53%398.24M | 0.50%397.85M | 0.97%398.51M | 0.95%397.45M | 0.95%397.45M | 13.92%396.12M | 14.29%395.88M | 14.12%394.68M |
Retained earnings | 20.75%260.96M | 20.75%260.96M | 21.82%249.98M | 25.34%237.03M | 29.34%224.74M | 31.81%216.12M | 31.81%216.12M | 36.50%205.21M | 35.83%189.12M | 35.57%173.76M |
Gains losses not affecting retained earnings | 5.39%-63M | 5.39%-63M | 51.03%-46.14M | 16.62%-67.78M | -5.35%-71.63M | 10.27%-66.59M | 10.27%-66.59M | -11.30%-94.24M | -29.59%-81.3M | -71.05%-68M |
Total stockholders'equity | 24.09%799.47M | 24.09%799.47M | 15.75%699.52M | 10.58%664.53M | 8.59%649.03M | 10.99%644.26M | 10.99%644.26M | 18.97%604.37M | 34.91%600.97M | 30.83%597.69M |
Total equity | 24.09%799.47M | 24.09%799.47M | 15.75%699.52M | 10.58%664.53M | 8.59%649.03M | 10.99%644.26M | 10.99%644.26M | 18.97%604.37M | 34.91%600.97M | 30.83%597.69M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |